ArticleBMC cancer2017
Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin.
Guntulu Ak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this paperpooled itcites it